Nadilaz (Azelastine Hydrochloride, Fluticasone Propionate)

Azelastine Hydrochloride, the active ingredient in Nadilaz, is an antihistamine/corticosteroid combination presented as a nasal formulation for intranasal use. It is indicated for the treatment of allergic rhinitis, including seasonal and perennial forms, by reducing nasal congestion, itching and sneezing in affected individuals.

GNH USA supplies Nadilaz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this prescription nasal product, ensuring consistent availability across diverse markets.

Nadilaz, a nasal antihistamine/corticosteroid combination, is used to manage allergic inflammation of the nasal passages.

Allergic rhinitis: provides relief of nasal congestion, itching, sneezing and rhinorrhea associated with allergic triggers. Seasonal allergic rhinitis: reduces symptoms during pollen or mold seasons, improving daily comfort and function. Perennial allergic rhinitis: controls year‑round nasal allergy symptoms, helping maintain consistent airway patency.

Nasal administration of Nadilaz may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Taste alteration: bitter or unpleasant taste in the mouth. - Nasal irritation: mild burning or stinging sensation. - Headache: transient mild headache. - Epistaxis: occasional mild nosebleeds.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis, facial swelling, or difficulty breathing. - Cortisol suppression: signs of adrenal insufficiency with prolonged use. - Nasal septum perforation: rare tissue damage leading to perforation.

Before prescribing Nadilaz, clinicians should consider several precautionary measures to ensure safe use. - Assess medical history: evaluate for hypersensitivity to azelastine, fluticasone or any excipients. - Monitor for infection: avoid use in patients with active nasal or sinus infections without physician guidance. - Limit duration: use the lowest effective dose for the shortest period necessary to control symptoms. - Avoid concurrent nasal sprays: do not combine with other intranasal medications unless directed. - Store at room temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Nadilaz can interact with other medicines, and interactions are classified by their clinical significance.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase systemic exposure to fluticasone, raising risk of corticosteroid‑related effects. - Live vaccines: intranasal corticosteroids may diminish immune response; avoid concurrent administration.

Moderate Interactions (Monitor Closely): - Other antihistamines: additive sedation or anticholinergic effects may occur. - Systemic corticosteroids: combined systemic effects could enhance cortisol‑related adverse events.